Estimation of Detailed Cardiac Doses for Pediatric Radiation Therapy Patients in National Wilms Tumor Study.

PURPOSE: Substructure-level heart dosimetry may improve the evaluation of long-term cardiac toxicity in childhood cancer survivors, but detailed pediatric heart models are limited. We developed age-specific heart models (1, 5, 10, and 15 years) using high-resolution imaging and integrated them into computational phantoms to estimate cardiac substructure doses in patients treated according to the National Wilms Tumor Study protocols and evaluate the impact of anatomic detail on radiation therapy dose estimates.

METHODS AND MATERIALS: Heart models with detailed substructures, including chambers, myocardium, arteries, valves, and conduction nodes, were developed from pediatric magnetic resonance and adult computed tomography images. These were incorporated into a size-dependent phantom library representing a wide range of pediatric body sizes. Patient-specific radiation therapy plans were reconstructed using the Pinnacle treatment planning system, and heart doses were calculated using both treatment planning system and Monte Carlo (MC) methods.

RESULTS

The developed heart models closely matched ICRP reference masses (within 2%). Treatment planning system and MC dose calculations showed strong agreement (median difference < 2%), so that MC-based doses were used for further analysis. Among 4,716 National Wilms Tumor Study patients treated with radiation therapy, the median whole heart dose was 4.2 Gy. Cardiac and substructure doses varied by treatment region, with the right atrium and left ventricular myocardium receiving higher doses (≤5.1 and 4.5 Gy), whereas coronary arteries and valves received lower doses (<1 Gy). In non-chest fields, substructure doses differed significantly from whole heart doses (P < .001), reflecting steep intracardiac dose gradients. Chest fields alone resulted in uniformly high cardiac doses with minimal variation.

CONCLUSION

Our results demonstrate that relying solely on whole heart dose may obscure clinically relevant exposure to critical substructures. Detailed heart models enable more accurate dosimetry and support improved risk assessment and safer pediatric radiation therapy planning to reduce long-term cardiac toxicity.